메뉴 건너뛰기




Volumn 23, Issue 6, 2008, Pages 395-396

Levetiracetam and restless leg syndrome;Levetiracetam y síndrome de piernas inquietas

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; GABAPENTIN;

EID: 48149085339     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (2)

References (8)
  • 1
    • 0036764008 scopus 로고    scopus 로고
    • Características e indicaciones del levetirazetam.
    • Herranz JL, Argumosa A. Características e indicaciones del levetirazetam. Rev Neurol 2002;35(Suppl. 1):110-6.
    • (2002) Rev Neurol , vol.35 , Issue.SUPPL. 1 , pp. 110-116
    • Herranz, J.L.1    Argumosa, A.2
  • 2
    • 0032563178 scopus 로고    scopus 로고
    • Evidence for a unique profile of levetiracem in rodent models of seizures and epilepsy
    • Klitgaard H, Matagne A, Gobert J, Wülfert E. Evidence for a unique profile of levetiracem in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191-206.
    • (1998) Eur J Pharmacol , vol.353 , pp. 191-206
    • Klitgaard, H.1    Matagne, A.2    Gobert, J.3    Wülfert, E.4
  • 3
    • 0034864144 scopus 로고    scopus 로고
    • Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?
    • Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 2001;42(Suppl. 4):13-8.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 4 , pp. 13-18
    • Klitgaard, H.1
  • 5
    • 0033811027 scopus 로고    scopus 로고
    • Multicenter double-blind, randomized, placebo-controlled trial of levetirazetam as add-on therapy in patients with refractory partial seizures
    • Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetirazetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179-86.
    • (2000) Epilepsia , vol.41 , pp. 1179-1186
    • Shorvon, S.D.1    Lowenthal, A.2    Janz, D.3    Bielen, E.4    Loiseau, P.5
  • 6
    • 0033775210 scopus 로고    scopus 로고
    • Efficacy and tolerability of levetiracetam 3,000 mg/day in patients with refractory partial onset seizures: A multicenter double-blind, responder-selected study evaluating monotherapy
    • Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3,000 mg/day in patients with refractory partial onset seizures: a multicenter double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276-83.
    • (2000) Epilepsia , vol.41 , pp. 1276-1283
    • Ben-Menachem, E.1    Falter, U.2
  • 7
    • 0034162331 scopus 로고    scopus 로고
    • A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam 2,000 mg daily and 4,000 mg daily, without titration in patients with refractory epilepsy
    • Betts T, Waegemans T, Crawford P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam 2,000 mg daily and 4,000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9:80-7.
    • (2000) Seizure , vol.9 , pp. 80-87
    • Betts, T.1    Waegemans, T.2    Crawford, P.3
  • 8
    • 33645562210 scopus 로고    scopus 로고
    • Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: Report of two cases
    • Della Marca G, Vollono C, Mariotti P, Mazza M, Mennuni GF, Tonali P, et al. Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: report of two cases. J Neurol Neurosurg Psychiatry 2006;566-7.
    • (2006) J Neurol Neurosurg Psychiatry , pp. 566-567
    • Della Marca, G.1    Vollono, C.2    Mariotti, P.3    Mazza, M.4    Mennuni, G.F.5    Tonali, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.